Surefire Medical Closes $12.8M Series D First Round Led by ORI Healthcare Fund

13:27 EST 2 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Multiple clinical studies verify significantly better liver cancer outcomes with use of unique expandable tip infusion systems Surefire Medical, Inc., the developer of site-specific delivery devices for the Interventi...

Other Sources for this Article

KOGS Communication
Edna Kaplan, 617-974-8659 (mobile)


More From BioPortfolio on "Surefire Medical Closes $12.8M Series D First Round Led by ORI Healthcare Fund"

Quick Search


Relevant Topics

Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...